Brief: Theranexus Obtains IND Status In The U.S. To Start Clinical Development Of BBDF 101

Thx Pharma SA

09/09/2021 17:15

Sept 9 (Reuters) - Theranexus SA  ALTHX.PA :
    * WITH THE BEYOND BATTEN DISEASE FOUNDATION (BBDF) OBTAINS
INVESTIGATIONAL NEW DRUG (IND) STATUS IN US TO START CLINICAL
DEVELOPMENT OF BBDF 101
    * APPROVAL FROM FDA TO LAUNCH A PHASE I/II CLINICAL TRIAL OF
DRUG
CANDIDATE BBDF 101 FOR JUVENILE BATTEN DISEASE
    * CLINICAL PROGRAM TO START WITH PHASE I/II BY THE END OF
2021

Source text for Eikon:  ID:nACT70926 
Further company coverage:  ALTHX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))